Wolverine Trading’s Immunic IMUX Stock Holding History

Wolverine Trading’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,170	Closed	-$18.1K	–	5544
2024 Q3	$18.1K	Buy	+1,170	New	+$16.7K	﹤0.01%	4651
2022 Q4	–	Sell	-1,340	Closed	-$42K	–	4457
2022 Q3	$42K	Buy	+1,340	New	+$56.1K	﹤0.01%	4198
2022 Q2	–	Sell	-1,330	Closed	-$154K	–	5080
2022 Q1	$154K	Buy	+1,330	New	+$154K	﹤0.01%	4587
2021 Q3	–	Sell	-1,610	Closed	-$198K	–	6563
2021 Q2	$198K	Buy	+1,610	New	+$223K	﹤0.01%	5031

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's IMUX Position: Q3 2025 in Review

Wolverine Trading opened a new position in Immunic (IMUX) in Q3 2025: 1,095 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #5556 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in IMUX as recently as Q4 2024.

Wolverine Trading first reported a position in IMUX in Q4 2021 and has held it in 7 quarters since. The position peaked at $132K in Q1 2022. 59 funds tracked by Wall St. Rank hold IMUX as of Q3 2025.

Wolverine Trading held 1,095 shares of Immunic worth $10.2K as of Q3 2025.
Immunic was a new Wolverine Trading position in Q3 2025.
Immunic made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5556 holding.
Wolverine Trading first reported a position in Immunic in Q4 2021 and has held it in 7 quarters since.
Wolverine Trading's Immunic position peaked at $132K in Q1 2022.
59 funds tracked by Wall St. Rank held Immunic as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.